ES2058451T3 - Un metodo para la preparacion de una composicion farmaceutica. - Google Patents

Un metodo para la preparacion de una composicion farmaceutica.

Info

Publication number
ES2058451T3
ES2058451T3 ES89122133T ES89122133T ES2058451T3 ES 2058451 T3 ES2058451 T3 ES 2058451T3 ES 89122133 T ES89122133 T ES 89122133T ES 89122133 T ES89122133 T ES 89122133T ES 2058451 T3 ES2058451 T3 ES 2058451T3
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical composition
drug
resistant
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89122133T
Other languages
English (en)
Inventor
Alan J Bitonti
Jules Freedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2058451T3 publication Critical patent/ES2058451T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE PRESENTAN COMPUESTOS FARMACEUTICOS QUE COMPRENDEN AGENTES ANTIPROTOZOOALES EN CONJUNCION CON UN DERIVATIVO DE BENZOCICLOALKANO DE FENOXIAMINO SUSTITUIDO QUE SON EFECTIVOS EN LA PREVENCION Y TRATAMIENTO DE INFECCIONES PROTOZOOALES RESISTENTES A LA MEDICACION PARTICULARMENTE, LA INFECCION DE MALARIA RESISTENTE A LA MEDICACION DE LOS HUMANOS.
ES89122133T 1988-12-01 1989-11-30 Un metodo para la preparacion de una composicion farmaceutica. Expired - Lifetime ES2058451T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27868988A 1988-12-01 1988-12-01

Publications (1)

Publication Number Publication Date
ES2058451T3 true ES2058451T3 (es) 1994-11-01

Family

ID=23065966

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89122133T Expired - Lifetime ES2058451T3 (es) 1988-12-01 1989-11-30 Un metodo para la preparacion de una composicion farmaceutica.

Country Status (11)

Country Link
US (1) US5134168A (es)
EP (1) EP0371508B1 (es)
JP (1) JP2867153B2 (es)
KR (1) KR0150630B1 (es)
AT (1) ATE91415T1 (es)
AU (1) AU622244B2 (es)
DE (1) DE68907566T2 (es)
DK (1) DK605589A (es)
ES (1) ES2058451T3 (es)
IE (1) IE62013B1 (es)
ZA (1) ZA899033B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
GB9315600D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Compounds
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
CA2596194A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
WO2007127930A2 (en) * 2006-04-28 2007-11-08 Kansas State University Research Foundation Compounds affecting gap junction activity
AU2009289846B2 (en) 2008-09-02 2014-10-16 Sanofi-Aventis Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
EP2368876A1 (en) * 2010-03-01 2011-09-28 Sanofi Derivatives of aminoindanes, their preparation and their application in therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409256A1 (fr) * 1977-11-18 1979-06-15 Roussel Uclaf Nouveaux derives de la 5h-benzocycloepten-7-amine et leurs sels, procede de preparation et application a titre de medicament
ZA885824B (en) * 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives

Also Published As

Publication number Publication date
EP0371508A1 (en) 1990-06-06
DK605589A (da) 1990-06-02
EP0371508B1 (en) 1993-07-14
IE62013B1 (en) 1994-12-14
DE68907566T2 (de) 1993-12-09
US5134168A (en) 1992-07-28
AU622244B2 (en) 1992-04-02
KR900009068A (ko) 1990-07-02
KR0150630B1 (ko) 1998-10-15
JP2867153B2 (ja) 1999-03-08
DE68907566D1 (de) 1993-08-19
ZA899033B (en) 1990-09-26
JPH02184623A (ja) 1990-07-19
ATE91415T1 (de) 1993-07-15
AU4574689A (en) 1990-06-07
IE893839L (en) 1990-06-01
DK605589D0 (da) 1989-11-30

Similar Documents

Publication Publication Date Title
ATE134506T1 (de) Orale präparate
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
CY1107598T1 (el) Η χρηση αναβολικων παραγοντων, αντι-καταβολικων παραγοντων, αντιοξειδωτικων παραγοντων, και αναλγητικων για προστασια, θepαπεια και επιδιορθωση συνδετικου ιστου σε ανθρωπους και ζωα
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
ES2045348T3 (es) Metodo para preparar derivados de lactamimida para el tratamiento o la prevencion de paludismo farmaco-resistente.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
EP0325129A3 (en) Disubstituted pyridines
BR9200332A (pt) Agente preventivo contra doencas infecciosas de crustaceos e agente estimulante,racao,e metodo para a preparacao de uma racao
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
NZ231320A (en) Aqueous oral preparations of diclofenac
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
ZA81473B (en) 5-amino-tetayole derivatives of retinoic acids, their preparation and pharmaceutical formulations containg these derivatives
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
CO5031290A1 (es) Formulacion lo
EP0539516A4 (es)
IT1232796B (it) Composizioni sinergisticamente attive e procedimento per la loro preparazione.
ITMI911535A1 (it) Derivati di una pirrolo-piridina, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
IT8821137A0 (it) Fosfatidilcoline idrosolubili, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
CO4700451A1 (es) Dimaleato de n,n-dietil-8, 8-dipropil-2-azaspiro[4.5] decano-2-propanamina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 371508

Country of ref document: ES